StockData
Cadre Holdings, Inc. logo

Cadre Holdings, Inc. (CDRE) stock

CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 15/3015% above fair value
$33.42+0.34 (+1.03%)

Close on Nov 13, 2026Market cap $1.43BP/E 36.7Yield 1.14%

Cadre r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $11.40M, up 36.0% from the year before. The highest annual figure on record is $11.40M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.40M+36.0%
FY2024Dec 31, 2024$8.38M+20.5%
FY2023Dec 31, 2023$6.95M-1.9%
FY2022Dec 31, 2022$7.09M+9.7%
FY2021Dec 31, 2021$6.46M+14.7%
FY2020Dec 31, 2020$5.63M–

More Cadre figures

See a number that looks wrong?